TY - JOUR
T1 - Primary progressive aphasias and apraxia of speech
AU - Botha, Hugo
AU - Josephs, Keith A.
N1 - Funding Information:
Dr Botha receives research/ grant support from the National Institutes of Health (R01 DC012519-06). Dr Josephs receives research/grant support from the National Institutes of Health (R01 AG37491, R01NS89757, R01 DC14942).
Funding Information:
This work was supported by grants from the National Institutes of Health (R01 AG37491, R01NS89757, R01 DC14942).
Publisher Copyright:
© Lippincott Williams & Wilkins. © 2019 American Academy of Neurology.
PY - 2019/2/1
Y1 - 2019/2/1
N2 - PURPOSE OF REVIEW This article reviews two of the primary progressive aphasias (PPAs), disorders characterized by the early and predominant impairment of language, and primary progressive apraxia of speech, a degenerative motor speech disorder that is closely related to PPA. An outline of the history and controversy surrounding how these disorders are classified is provided before the article focuses on each disorder's clinical and imaging features. RECENT FINDINGS Over the past decade, the classification of degenerative speech and language disorders has been refined. Clinical, imaging, and pathologic evidence suggests that primary progressive apraxia of speech is a distinct degenerative disorder. Furthermore, multiple lines of evidence have highlighted issues with nonfluent/agrammatic variant PPA, which complicates the diagnosis, prognosis, and study of this disorder. Semantic variant PPA, while not without controversy, remains one of the most well-defined disorders, with good clinicopathologic correlation. SUMMARY Accurate classification and diagnosis of these degenerative speech and language disorders is crucial in clinical practice and ongoing research efforts. For nonfluent/agrammatic variant PPA, the authors suggest emphasizing agrammatism as the core inclusion criterion and taking care not to include patients with isolated or predominant apraxia of speech. Isolated apraxia of speech can be the manifestation of a degenerative disease and, based on the different prognosis, should be recognized as distinct from PPA. Finally, it is important to recognize that some patients with semantic dementia, despite sharing the same pathologic associations, may not meet criteria for PPA.
AB - PURPOSE OF REVIEW This article reviews two of the primary progressive aphasias (PPAs), disorders characterized by the early and predominant impairment of language, and primary progressive apraxia of speech, a degenerative motor speech disorder that is closely related to PPA. An outline of the history and controversy surrounding how these disorders are classified is provided before the article focuses on each disorder's clinical and imaging features. RECENT FINDINGS Over the past decade, the classification of degenerative speech and language disorders has been refined. Clinical, imaging, and pathologic evidence suggests that primary progressive apraxia of speech is a distinct degenerative disorder. Furthermore, multiple lines of evidence have highlighted issues with nonfluent/agrammatic variant PPA, which complicates the diagnosis, prognosis, and study of this disorder. Semantic variant PPA, while not without controversy, remains one of the most well-defined disorders, with good clinicopathologic correlation. SUMMARY Accurate classification and diagnosis of these degenerative speech and language disorders is crucial in clinical practice and ongoing research efforts. For nonfluent/agrammatic variant PPA, the authors suggest emphasizing agrammatism as the core inclusion criterion and taking care not to include patients with isolated or predominant apraxia of speech. Isolated apraxia of speech can be the manifestation of a degenerative disease and, based on the different prognosis, should be recognized as distinct from PPA. Finally, it is important to recognize that some patients with semantic dementia, despite sharing the same pathologic associations, may not meet criteria for PPA.
UR - http://www.scopus.com/inward/record.url?scp=85060933027&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85060933027&partnerID=8YFLogxK
U2 - 10.1212/CON.0000000000000699
DO - 10.1212/CON.0000000000000699
M3 - Review article
C2 - 30707189
AN - SCOPUS:85060933027
SN - 1080-2371
VL - 25
SP - 101
EP - 127
JO - CONTINUUM Lifelong Learning in Neurology
JF - CONTINUUM Lifelong Learning in Neurology
IS - 1
ER -